|
SGO Taskforce for Board Certification Support Statistic Webinar Series - Part 3 |
|
Enduring |
|
$0.00 |
|
Ocular Toxicities with ADCs Companion Card |
|
Enduring |
|
$0.00 |
|
SGO Taskforce for Board Certification Support Statistic Webinar Series - Part 4 |
|
Enduring |
|
$0.00 |
|
Treatment Related Cardiotoxicity: Review and Management Companion Card |
|
Enduring |
|
$0.00 |
|
Basics of Gyn Oncology Coding On-Demand Webinar (2024) |
|
Enduring |
|
$0.00 |
|
Highlights from the SGO 2024 Annual Meeting on Women's Cancer |
|
Enduring |
|
$195.00 |
|
Molecular Target: Human Epidermal Growth Factor Receptor 2 (HER2) |
|
Enduring |
|
$0.00 |
|
SGO Late Breaking: 2024 FDA Approvals |
|
Enduring |
|
$0.00 |
|
SGO Late Breaking: SGO 2024 |
|
Enduring |
|
$0.00 |
|
SGO Late Breaking: ASCO 2024 |
|
Enduring |
|
$0.00 |
|
2024 Allied Health Professionals Meeting On-Demand Package |
|
Enduring |
|
$400.00 |
|
Targeted Therapy Advanced Bootcamp |
|
Enduring |
|
$95.00 |
|
HIPEC in Gynecologic Oncology: State of the science and a practical how to On-Demand Webinar |
|
Enduring |
|
$35.00 |
|
Molecular Target: Folate Receptor Alpha (FOLR1) |
|
Enduring |
|
$0.00 |
|
Omentectomy |
|
Enduring |
|
$0.00 |
Facebook
X
LinkedIn
Forward